Your browser doesn't support javascript.
loading
Response to programmed cell death protein 1 antibody in patients with Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.
He, Wen-Zhuo; Huang, Yu-Hua; Hu, Wan-Ming; Wang, Fang; Xu, Yu-Xia; Yi, Jia-Hong; Xue, Ju; Yang, Yuan-Zhong; Chao, Xiao-Ying; Lin, Han-Bin; Guo, Gui-Fang; Yun, Jing-Ping; Xia, Liang-Ping.
Afiliação
  • He WZ; VIP Region, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China.
  • Huang YH; Department of Pathology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China.
  • Hu WM; Department of Pathology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China.
  • Wang F; Department of Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, PR China.
  • Xu YX; Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China.
  • Yi JH; VIP Region, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China.
  • Xue J; VIP Region, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China.
  • Yang YZ; Department of Pathology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China.
  • Chao XY; Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China; Zhongshan Institute for Drug Discovery, SIMM, Chinese Academy of Sciences, Zhongshan, Guangdong, China.
  • Lin HB; Zhongshan Institute for Drug Discovery, SIMM, Chinese Academy of Sciences, Zhongshan, Guangdong, China; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. Electronic address: linhanbin@simm.ac.cn.
  • Guo GF; VIP Region, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China. Electronic address: guogf@sysucc.org.cn.
  • Yun JP; Department of Pathology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China. Electronic address: yunjp@sysucc.org.cn.
  • Xia LP; VIP Region, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China. Electronic address: xialp@sysucc.org.cn.
Eur J Cancer ; 194: 113337, 2023 11.
Article em En | MEDLINE | ID: mdl-37862797

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma / Infecções por Vírus Epstein-Barr Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma / Infecções por Vírus Epstein-Barr Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article